Scientists Race to Test Treatments as Ebola Outbreak Widens
Global research efforts accelerate as scientists scramble to test new vaccines and treatments in response to a widening Ebola outbreak.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Scientists and organizations initiated an accelerated effort to develop vaccines following an Ebola outbreak, including the securing of funding for Bundibugyo ebolavirus candidates. The story quieted without a definitive conclusion in the coverage.
Epilogue added 140d ago, after coverage quieted.
The brief
An international push is underway to fast-track the development and testing of vaccine candidates targeting the Ebola virus, specifically the Bundibugyo strain. Coverage from The New York Times, Scientific American, and Semafor highlights the urgent race among scientists to establish effective medical countermeasures.
Reporting from NDTV notes that India is increasing its involvement in the global response, while bio-itworld.com, CEPI, and PR Newswire detail the financial backing provided to institutions like Moderna, Oxford, and Soligenix to advance specific vaccine projects. Future reports will track the progress of these funded vaccine candidates through development phases.
Coverage does not yet specify the timeline for human trials or the expected distribution of these treatments.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: unsupported claims removed (83% supported) Updated 140d ago.
Quick answers
Which specific strain of the virus are researchers targeting?
Multiple reports indicate a primary focus on the Bundibugyo ebolavirus.
Who is funding the development of these vaccines?
CEPI is identified as a primary funding source, with additional applications for development funds submitted by various pharmaceutical companies.
Are there results from the vaccine testing yet?
The current coverage focuses on the race to develop and fund these treatments; information regarding clinical test results is not yet specified.
Coverage (8)
- India Steps Up Global Ebola Response With New Vaccine Candidate Amid Outbreak NDTV · 143d ago
- Inside the race to develop a new Ebola vaccine Scientific American · 144d ago
- Scientists race to develop Ebola vaccines Semafor · 144d ago
- Moderna and Oxford Secure $60 Million CEPI Funding to Advance Ebola Bundibugyo Vaccine Development During Congo Outbreak bio-itworld.com · 144d ago
- Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccine PR Newswire · 144d ago
- Opinion The Boston Globe · 144d ago
- CEPI awards Public Health Vaccines US$1.9m to accelerate Bundibugyo ebolavirus vaccine CEPI · 144d ago
- Scientists Race to Test Treatments as Ebola Outbreak Widens The New York Times · 144d ago
Topics
Related trends
Ebola survivors comfort sick children in Congo's isolation wards
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Ebola outbreak kills more than 5,300 people in DR Congo
Ebola survivors are providing emotional support to sick children in isolation wards amidst a deadly outbreak in the Democratic Republic of Congo.
Ebola kills over 5,300 in fastest-growing outbreak on record
An Ebola outbreak in the Democratic Republic of Congo kills over 5,300 people in the fastest-growing such event on record.
'Relentless' Ebola Has Nearly 50% Lethality Rate in Congo
An unprecedented Ebola outbreak in Congo exhibits a nearly 50 percent lethality rate, prompting urgent global warnings from officials.
I’m in My 30s. I Took a Medical Step That’s Usually Reserved for “Old” People. I Have No Regrets.
Recent reporting examines the medical decision of receiving a shingles vaccine at a younger age.
Ebola outbreak kills more than 5,000 people in Democratic Republic of Congo
An Ebola outbreak in the Democratic Republic of Congo has resulted in more than 5,000 deaths, according to reports from Sky News.